Truemeds, secures $85M in Series C funding led by Accel and Peak XV Partners

Truemeds, an e-pharmacy and telehealth platform, raised $85M in Series C funding led by Accel and Peak XV, with WestBridge Capital and Info Edge Ventures participating. Funds will drive non-metro expansion, team growth, and a Bengaluru office, aiming to triple reach. Founded in 2019, Truemeds offers affordable medicine alternatives, launched an iOS app, and plans diagnostics. FY24 revenue doubled to ₹315 crore, with reduced losses, competing with PharmEasy and Tata 1mg.